Investor AB’s Neuronetics STIM Stock Holding History

Investor AB’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,794,228	Closed	-$19.9M	–	3
2020 Q4	$19.9M	Hold	1,794,228	–	–	0.77%	2
2020 Q3	$8.72M	Hold	1,794,228	–	–	0.36%	3
2020 Q2	$3.46M	Hold	1,794,228	–	–	0.15%	3
2020 Q1	$3.39M	Hold	1,794,228	–	–	0.18%	3
2019 Q4	$8.06M	Hold	1,794,228	–	–	0.38%	3
2019 Q3	$14.9M	Hold	1,794,228	–	–	0.76%	2
2019 Q2	$22.4M	Hold	1,794,228	–	–	1.18%	2
2019 Q1	$27.4M	Hold	1,794,228	–	–	1.58%	2
2018 Q4	$34.7M	Hold	1,794,228	–	–	2.04%	2
2018 Q3	$57.5M	Sell	1,794,228 -8	-0%	-$243	3.34%	2
2018 Q2	$47.7M	Buy	+1,794,236	New	+$48.8M	2.61%	2

Other funds holding STIM

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Investor AB's STIM Position: Q1 2021 in Review

Investor AB sold out of Neuronetics (STIM) in Q1 2021, closing a stake of 1,794,228 shares — an estimated $19.9M sold.

Investor AB first reported a position in STIM in Q2 2018 and held it in 11 quarters. The position peaked at $57.5M in Q3 2018. 83 funds tracked by Wall St. Rank hold STIM as of Q1 2021.

Investor AB reported no remaining Neuronetics position as of Q1 2021 after selling out during the quarter.
Investor AB sold 1,794,228 Neuronetics shares in Q1 2021, an estimated $19.9M.
Investor AB first reported a position in Neuronetics in Q2 2018 and held it in 11 quarters.
Investor AB's Neuronetics position peaked at $57.5M in Q3 2018.
83 funds tracked by Wall St. Rank held Neuronetics as of Q1 2021.

Based on Investor AB's 13F filing for Q1 2021, filed 17 May 2021.